Salmonella blood stream infections in a tertiary care setting in Ghana

BMC Infectious Diseases

Eric Sampene Donkor¹  Naa Okaikor Addison²  Noah Obeng-Nkrumah¹  Appiah-Korang Labi² 

[1] Microbiology Department, University of Ghana Medical School, Accra, West Africa, Ghana;Department of Microbiology, Korle-Bu Teaching Hospital, Accra, West Africa, Ghana

关键词: Risk factors;    Resistance;    Antibiotic;    Salmonella;    Ghana;   

Others  :  1090236
DOI  :  10.1186/s12879-014-0697-7

 received in 2014-09-22, accepted in 2014-12-11,  发布年份 2014

【 摘 要 】

Background

Despite the clinical significance of Salmonella infections, surveillance data worldwide remains limited and is more so exemplified by the lack of reports from Africa especially in eastern, central and western Africa. This study reports on Salmonella serotypes as significant causes of blood stream infections (BSI) and multidrug antibiotic resistance at Korle-Bu Teaching Hospital in Accra, Ghana.

Methods

Antibiogram patterns, seasonal variations in disease incidence and predisposing factors for infection with Salmonella serotypes were analyzed retrospectively over a 4-year period from January 2010 to December 2013. Blood cultures were processed with BACTEC 9240 blood culture system. Speciation was done with BBL Crystal Enteric/Nonfermenter identification system®, and with slide agglutination using specific antisera. Antimicrobial susceptibility testing was carried out by the Kirby-Bauer disc diffusion method according to Clinical and Laboratory Standard Institute guidelines.

Results

We report a 6.5% (n = 181/2768) prevalence of Salmonella bacteraemia at the Korle-Bu Teaching Hospital; with a preponderance of non-typhoidal salmonellae (NTS) over typhoidal salmonella (TS) (n = 115/181, 63.5% versus n = 66/181, 36.5%; P-value <0.002). Children under 5 years bore the brunt of the disease (n = 93/174, 53.4%). Resistance to ciprofloxacin (n = 1/127, 0.7%), amikacin (n = 3/81, 3.7%), and cefotaxime (n = 6/99, 6.1%) remained low, despite high levels of multidrug resistant Salmonella phenotypes (n = 81/181, 44.2%). In multivariate analysis, and among patients with Salmonella BSI, those < 1 year old had reduced risk of non-typhoidal infections [Odds ratio, 0.51; 95% confidence interval (95% CI), 0.16-0.92, P-value 0.021]. Similarly, patients with cefuroxime resistant strans were at increased risk of having multidrug resistant Salmonella BSI (OR, 8.97; 95% CI, 3.62-24.15; P-value, 0.001).

Conclusions

Salmonellae, predominantly NTS, account for a reasonable low proportion of positive blood cultures in our tertiary care setting; but with significant multidrug resistant phenotypes and low ciprofloxacin and cefotaxime resistance.

【 授权许可】

   
2014 Labi et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Crump JA, Luby SP, Mintz ED: The global burden of typhoid fever. Bull World Health Organ 2004, 82:346-353.
• [2]Ekdahl K, De Jong B, Wollin R, Andersson Y: Travel-associated non-typhoidal salmonellosis: geographical and seasonal differences and serotype distribution. Clin Microbiol Infect 2005, 11:138-144.
• [3]Darton TC, Blohmke CJ, Pollard AJ: Typhoid epidemiology, diagnostics and the human challenge model. Curr Opin Gastroenterol 2014, 30:7-17.
• [4]Evans JA, Adusei A, Timmann C, May J, Mack D, Agbenyega T, Horstmann RD, Frimpong E: High mortality of infant bacteraemia clinically indistinguishable from severe malaria. QJM 2004, 97:591-597.
• [5]Schwarz NG, Sarpong N, Hünger F, Marks F, Acquah SE, Agyekum A, Nkrumah B, Loag W, Hagen RM, Evans JA, Dekker D, Fobil JN, Meyer CG, May J, Adu-Sarkodie Y: Systemic bacteraemia in children presenting with clinical pneumonia and the impact of non-typhoid salmonella (NTS). BMC Infect Dis 2010, 10:319. BioMed Central Full Text
• [6]Phoba M-F, Boeck HD, Ifeka BB, Dawili J, Lunguya O, Vanhoof R, Muyembe J-J, Geet CV, Bertrand S, Jacobs J: Epidemic increase in Salmonella bloodstream infection in children, Bwamanda, the Democratic Republic of Congo. Eur J Clin Microbiol Infect Dis 2014, 33:79-87.
• [7]Morpeth SC, Ramadhani HO, Crump JA: Invasive Non-Typhi Salmonella Disease in Africa. Clin Infect Dis 2009, 49:606-611.
• [8]Biggs HM, Lester R, Nadjm B, Mtove G, Todd JE, Kinabo GD, Philemon R, Amos B, Morrissey AB, Reyburn H, Crump JA: Invasive Salmonella infections in areas of high and low malaria transmission intensity in Tanzania.Clin Infect Dis 2013, 58(5):638–647.
• [9]Kothari A, Pruthi A, Chugh TD: The Burden of Enteric Fever.J Infect Dev Ctries 2008, 2(4):253–259.
• [10]Mohanty S, Renuka K, Sood S, Das BK, Kapil A: Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006, 134:961-966.
• [11]Were T, Davenport GC, Hittner JB, Ouma C, Vulule JM, Ong’echa JM, Perkins DJ: Bacteremia in Kenyan Children Presenting with Malaria. J Clin Microbiol 2011, 49:671-676.
• [12]MacLennan CA: Out of Africa: Links Between Invasive Nontyphoidal Salmonella Disease, Typhoid Fever, and Malaria.Clin Infect Dis 2013, doi:10.1093/cid/cit803.
• [13]Paniker CKJ, Vimala KN: Transferable Chloramphenicol Resistance in Salmonella typhi. Nature 1972, 239:109-110.
• [14]Ackers M, Puhr ND, Tauxe RV, Mintz ED: Laboratory-based surveillance of salmonella serotype typhi infections in the united states: Antimicrobial resistance on the rise. JAMA 2000, 283:2668-2673.
• [15]Korle-Bu Teaching Hospital: Annual Report Korle-Bu Teaching Hospital. Accra, Ghana: Korle-Bu Teaching Hospital; 2011.
• [16]Cockerill FR, Wikler MA, Alder J, Dudley MN, Eliopoulos GM, Ferraro MJ, Hardy DJ, Hecht DW, Hindler JA, Patel JB, Powell M, Swenson JM, Thompson Jnr RB, Traczewski MM, Turnidge JD, Weinstein MP, Zimmer BM: CLSI. Performance standards for antimicrobial susceptibility testing; Twenty-second informational supplement. CLSI document M100-S22. Volume 32. Wayne, PA: Clinical and Laboratory Standard Institute, 2012.
• [17]Magiorakos A, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF: bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
• [18]Groß U, Amuzu SK, de Ciman R, Kassimova I, Groß L, Rabsch W, Rosenberg U, Schulze M, Stich A, Zimmermann O: Bacteremia and Antimicrobial Drug Resistance over Time, Ghana. Emerg Infect Dis 2011, 17:1879-1882.
• [19]Wilkens J, Newman MJ, Commey JO, Seifert H: Salmonella bloodstream infection in Ghanaian children. Clin Microbiol Infect 1997, 3:616-620.
• [20]Marks F, Adu-Sarkodie Y, Hünger F, Sarpong N, Ekuban S, Agyekum A, Nkrumah B, Schwarz NG, Favorov MO, Meyer CG, May J: Typhoid Fever among Children, Ghana. Emerg Infect Dis 2010, 16:1796-1797.
• [21]Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA: Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 2012, 379:2489-2499.
• [22]Reddy EA, Shaw AV, Crump JA: Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10:417-432.
• [23]Gordon MA, Graham SM, Walsh AL, Wilson L, Phiri A, Molyneux E, Zijlstra EE, Heyderman RS, Hart CA, Molyneux ME: Epidemics of Invasive Salmonella enterica Serovar Enteritidis and S. enterica Serovar Typhimurium Infection Associated with Multidrug Resistance among Adults and Children in Malawi. Clin Infect Dis 2008, 46:963-969.
• [24]Bronzan RN, Taylor TE, Mwenechanya J, Tembo M, Kayira K, Bwanaisa L, Njobvu A, Kondowe W, Chalira C, Walsh AL, Phiri A, Wilson LK, Molyneux ME, Graham SM: Bacteremia in Malawian Children with Severe Malaria: Prevalence, Etiology, HIV Coinfection, and Outcome. J Infect Dis 2007, 195:895-904.
• [25]Maltha J, Guiraud I, Kaboré B, Lompo P, Ley B, Bottieau E, Van Geet C, Tinto H, Jacobs J: Frequency of Severe Malaria and Invasive Bacterial Infections among Children Admitted to a Rural Hospital in Burkina Faso. PLoS One 2014, 9:e89103.
• [26]Kouadio KY, Aman A, Ochou AD, Ali KE, Asamoi PA: Rainfall variability patterns in West Africa: Case of Cote d?Ivoire and Ghana.J Environ Scince Eng 2011, 5:1229–1238.
• [27]Graham S: Nontyphoidal salmonellosis in Africa. Curr Opin Infect Dis Oct 2010 2010, 23:409-414.
• [28]Lunguya O, Lejon V, Phoba M-F, Bertrand S, Vanhoof R, Verhaegen J, Smith AM, Keddy KH, Muyembe-Tamfum J-J, Jacobs J: Salmonella Typhi in the Democratic Republic of the Congo: Fluoroquinolone Decreased Susceptibility on the Rise. PLoS Negl Trop Dis 2012, 6:e1921.
• [29]Ministry of Health: Republic of Ghana Standard Treatment Guidelines. Sixth edition. 2010. Accra, Ghana: Ghana National Drug Programme, 362–365.
• [30]Kumar S, Rizvi M, Berry N: Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008, 57:1247-1250.
• [31]Nielsen MV, Sarpong N, Krumkamp R, Dekker D, Loag W, Amemasor S, Agyekum A, Marks F, Huenger F, Krefis AC, Hagen RM, Adu-Sarkodie Y, May J, Schwarz NG: Incidence and Characteristics of Bacteremia among Children in Rural Ghana. PLoS One 2012, 7:e44063.